A detailed history of Lgt Group Foundation transactions in Insulet Corp stock. As of the latest transaction made, Lgt Group Foundation holds 1,393 shares of PODD stock, worth $324,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,393
Holding current value
$324,220
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$161.02 - $206.98 $224,300 - $288,323
1,393 New
1,393 $281,000
Q4 2023

Feb 06, 2024

BUY
$127.77 - $221.42 $138,374 - $239,797
1,083 New
1,083 $234,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $16.2B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.